P2Y 1 receptors mediate inhibitory neuromuscular transmission in the rat colon

British Journal of Pharmacology

Volumn 158, Issue 6, 2009, Pages 1641-1652

  Grasa, Laura ^a,b   Gil, Víctor ^a   Gallego, Diana ^a,b,c   Martín, Maria Teresa ^a,b,c   Jiménez, Marcel ^a,b,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Gastrointestinal; Inhibitory neuromuscular transmission; MRS2179; MRS2279; MRS2500; Nitric oxide; P2Y 1 receptors; Smooth muscle

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 4 (2 IODO 6 METHYLAMINO 9H PURIN 9 YL) 2 PHOSPHONOOXYBICYCLO[3.1.0]HEXANE 1 METHANOL; ADENOSINE TRIPHOSPHATE; MRS 2279; N(G) NITROARGININE; NITROPRUSSIDE SODIUM; PURINERGIC P2Y1 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT FUNCTION; INHIBITORY JUNCTION POTENTIAL; MALE; MEMBRANE POTENTIAL; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; COLON; DRUG DELIVERY SYSTEMS; ELECTRIC STIMULATION; GASTROINTESTINAL MOTILITY; MALE; MICROELECTRODES; MYOCYTES, SMOOTH MUSCLE; NEUROMUSCULAR JUNCTION; NITRIC OXIDE; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2;

EID: 70350523345     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00454.x     Document Type: Article

References (39)

1. Alberti E, Mikkelsen HB, Larsen JO, Jimenez M (2005). Motility patterns and distribution of interstitial cells of Cajal and nitrergic neurons in the proximal, mid- and distal-colon of the rat. Neurogastroenterol Motil 17 : 133 147.
2. Alexander SP, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 S209.
3. Baurand A, Gachet C (2003). The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179. Cardiovasc Drug Rev 21 : 67 76.
4. Baurand A, Raboisson P, Freund M, Leon C, Cazenave JP, Bourguignon JJ et al. (2001). Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol 412 : 213 221.
5. Bornstein JC (2008). Purinergic mechanisms in the control of gastrointestinal motility. Purinergic Signal 4 : 197 212.
6. Boyer JL, Mohanram A, Camaioni E, Jacobson KA, Harden TK (1998). Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br J Pharmacol 124 : 1 3.
7. Boyer JL, Adams M, Ravi RG, Jacobson KA, Harden TK (2002). 2-Chloro N(6)-methyl-(N)-methanocarba-2′-deoxyadenosine-3′, 5′-bisphosphate is a selective high affinity P2Y(1) receptor antagonist. Br J Pharmacol 135 : 2004 2010.
8. Burnstock G (2007). Purine and pyrimidine receptors. Cell Mol Life Sci 64 : 1471 1483.
9. Burnstock G (2008). The journey to establish purinergic signalling in the gut. Neurogastroenterol Motil 20 (Suppl. 1 8 19.
10. Burnstock G, Campbell G, Satchell D, Smythe A (1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40 : 668 688.
11. Camaioni E, Boyer JL, Mohanram A, Harden TK, Jacobson KA (1998). Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors. J Med Chem 41 : 183 190.
12. Cattaneo M, Lecchi A, Ohno M, Joshi BV, Besada P, Tchilibon S et al. (2004). Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor. Biochem Pharmacol 68 : 1995 2002.
13. Crist JR, He XD, Goyal RK (1992). Both ATP and the peptide VIP are inhibitory neurotransmitters in guinea-pig ileum circular muscle. J Physiol 447 : 119 131.
14. De Man JG, De Winter BY, Seerden TC, De Schepper HU, Herman AG, Pelckmans PA (2003). Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved. Br J Pharmacol 140 : 1108 1116.
15. Gallego D, Hernandez P, Clave P, Jimenez M (2006). P2Y1 receptors mediate inhibitory purinergic neuromuscular transmission in the human colon. Am J Physiol Gastrointest Liver Physiol 291 : G584 G594.
16. Gallego D, Gil V, Aleu J, Auli M, Clave P, Jimenez M (2008a). Purinergic and nitrergic junction potential in the human colon. Am J Physiol Gastrointest Liver Physiol 295 : G522 G523.
17. Gallego D, Vanden Berghe P, Farre R, Tack J, Jimenez M (2008b). P2Y1 receptors mediate inhibitory neuromuscular transmission and enteric neuronal activation in small intestine. Neurogastroenterol Motil 20 : 159 168.
18. Gao N, Hu HZ, Zhu MX, Fang X, Liu S, Gao C et al. (2006). The P2Y purinergic receptor expressed by enteric neurones in guinea-pig intestine. Neurogastroenterol Motil 18 : 316 323.
19. Giaroni C, Knight GE, Ruan HZ, Glass R, Bardini M, Lecchini S et al. (2002). P2 receptors in the murine gastrointestinal tract. Neuropharmacology 43 : 1313 1323.
20. Gwynne RM, Bornstein JC (2009). Electrical stimulation of the mucosa evokes slow EPSPs mediated by NK1 tachykinin receptors and by P2Y1 purinoceptors in different myenteric neurons. Am J Physiol Gastrointest Liver Physiol 297 : 6179 6186.
21. He XD, Goyal RK (1993). Nitric oxide involvement in the peptide VIP-associated inhibitory junction potential in the guinea-pig ileum. J Physiol 461 : 485 499.
22. Hechler B, Nonne C, Roh EJ, Cattaneo M, Cazenave JP, Lanza F et al. (2006). MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine- 3′,5′-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice. J Pharmacol Exp Ther 316 : 556 563.
23. Hu HZ, Gao N, Zhu MX, Liu S, Ren J, Gao C et al. (2003). Slow excitatory synaptic transmission mediated by P2Y1 receptors in the guinea-pig enteric nervous system. J Physiol 550 : 493 504.
24. Kaiser RA, Buxton IL (2002). Nucleotide-mediated relaxation in guinea-pig aorta: selective inhibition by MRS2179. Br J Pharmacol 135 : 537 545.
25. Keef KD, Du C, Ward SM, McGregor B, Sanders KM (1993). Enteric inhibitory neural regulation of human colonic circular muscle: role of nitric oxide. Gastroenterology 105 : 1009 1016.
26. Kim HS, Barak D, Harden TK, Boyer JL, Jacobson KA (2001). Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking. J Med Chem 44 : 3092 3108.
27. King BF (2002). 2-Chloro-N6-methyl-(N)-methanocarba-2′- deoxyadenosine-3′,5′-bisphosphate is a selective high affinity P2Y1 receptor antagonist: commentary on Boyer et al. Br J Pharmacol 135 : 1839 1840.
28. King BF, Townsend-Nicholson A (2008). Involvement of P2Y1 and P2Y11 purinoceptors in parasympathetic inhibition of colonic smooth muscle. J Pharmacol Exp Ther 324 : 1055 1063.
29. Lyster DJ, Bywater RA, Taylor GS, Watson MJ (1992). Effects of a nitric oxide synthase inhibitor on non-cholinergic junction potentials in the circular muscle of the guinea pig ileum. J Auton Nerv Syst 41 : 187 196.
30. McDonnell B, Hamilton R, Fong M, Ward SM, Keef KD (2008). Functional evidence for purinergic inhibitory neuromuscular transmission in the mouse internal anal sphincter. Am J Physiol Gastrointest Liver Physiol 294 : G1041 G1051.
31. Monro RL, Bertrand PP, Bornstein JC (2004). ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the guinea pig ileum. J Physiol 556 : 571 584.
32. Pluja L, Fernandez E, Jimenez M (1999). Neural modulation of the cyclic electrical and mechanical activity in the rat colonic circular muscle: putative role of ATP and NO. Br J Pharmacol 126 : 883 892.
33. Ralevic V, Burnstock G (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50 : 413 492.
34. Ravi RG, Kim HS, Servos J, Zimmermann H, Lee K, Maddileti S et al. (2002). Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists. J Med Chem 45 : 2090 2100.
35. Van Crombruggen K, Van Nassauw L, Timmermans JP, Lefebvre RA (2007). Inhibitory purinergic P2 receptor characterisation in rat distal colon. Neuropharmacology 53 : 257 271.
36. Von Kugelgen I (2006). Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110 : 415 432.
37. Wang GD, Wang XY, Hu HZ, Liu S, Gao N, Fang X et al. (2007). Inhibitory neuromuscular transmission mediated by the P2Y1 purinergic receptor in guinea pig small intestine. Am J Physiol Gastrointest Liver Physiol 292 : G1483 G1489.
38. Wood JD (2006). The enteric purinergic P2Y1 receptor. Curr Opin Pharmacol 6 : 564 570.
39. Zizzo MG, Mule F, Serio R (2007). Inhibitory purinergic transmission in mouse caecum: role for P2Y1 receptors as prejunctional modulators of ATP release. Neuroscience 150 : 658 664.